Company Filing History:
1 out of 1,552 
1 out of 832,761 Years Active: 2004
Title: Innovations of Lawrence J Bonassar
Introduction
Lawrence J Bonassar is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of tissue engineering and regenerative medicine. With a total of 2 patents, his work focuses on innovative methods for creating living tissue constructs and improving patient treatment methods.
Latest Patents
One of his latest patents is related to the "Injection molding of living tissues." This invention features methods for making living tissue constructs with a predetermined shape. The process involves providing a negative mold, suspending isolated tissue precursor cells in a hydrogel, and introducing this composition into the mold. The gel formation is then induced to solidify the composition, resulting in a living tissue construct that can be removed from the mold after gel formation.
Another significant patent is the "Method of generating cartilage." This invention describes an improved method for administering live cells to patients. The composition includes live cells and biocompatible, biodegradable polymer microparticles. The method allows for the effective administration of the cell/microparticle composition to a treatment site, promoting new tissue formation or the secretion of biologically active molecules.
Career Highlights
Lawrence J Bonassar has worked at the University of Massachusetts, where he has contributed to various research initiatives in tissue engineering. His innovative approaches have garnered attention in the scientific community, leading to advancements in regenerative medicine.
Collaborations
He has collaborated with notable individuals such as Jon A Rowley and David J Mooney, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Lawrence J Bonassar's contributions to the field of tissue engineering are noteworthy, with his patents paving the way for advancements in medical treatments. His innovative methods continue to influence the development of new therapies for patients in need.